A Metabolic Gene Signature to Predict Breast Cancer Prognosis

Background: The existing metabolic gene signatures for predicting breast cancer outcomes only focus on gene expression data without considering clinical characteristics. Therefore, this study aimed to establish a predictive risk model combining metabolic enzyme genes and clinicopathological characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun, Liu, Pinbo, Zhang, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277072/
https://www.ncbi.nlm.nih.gov/pubmed/35847988
http://dx.doi.org/10.3389/fmolb.2022.900433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277072/
https://www.ncbi.nlm.nih.gov/pubmed/35847988
http://dx.doi.org/10.3389/fmolb.2022.900433

Ejemplares similares